台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    90.3
  • 漲跌
    ▲0.4
  • 漲幅
    +0.44%
  • 成交量
    308
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智擎 (4162)籌碼相關-元富-屏東 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-屏東 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/26692.15691.1091.1001,1060.00%
2025/05/23292.80292.4092.4001,1200.00%
2025/05/14291.10291.1091.6001,2580.00%
2025/05/13290.601291.6389.80-101,266-0.79%
2025/05/121190.71191.7090.60101,2980.77%
2025/05/09190.00190.4090.5001,3770.00%
2025/05/02390.80389.7089.7001,7760.00%
2025/04/11084.7000.0084.0001,8420.00%
2025/04/0800.00284.6084.60-21,801-0.11%
2025/04/0700.00089.0089.0001,7660.00%
2025/03/2000.002106.00106.00-21,713-0.12%
2025/03/180107.0000.00106.5001,7130.00%
2025/03/170106.5000.00105.0001,7140.00%
2025/03/130103.5000.00103.5001,7070.00%
2025/03/112107.0000.00107.0021,6970.12%
2025/03/070107.5030106.50107.50-301,665-1.80%
2025/03/0621113.621.1111.09111.0019.91,6471.21%
2025/03/0510.1114.0100.00115.5010.11,6450.61%
2025/02/1800.001112.50110.00-11,401-0.07%
2025/02/171111.501112.50112.5001,3970.00%
2025/02/1200.000.1111.00112.00-0.11,408-0.01%
2025/02/112.1110.291110.50109.001.11,3920.08%
2025/02/1000.000119.00118.5001,3370.00%
2025/02/070119.6400.00120.5001,3510.00%
2025/02/060119.331119.00119.00-11,329-0.07%
2025/02/051.1107.4500.00113.001.11,1940.09%
2024/11/2100.00196.2096.20-11,021-0.10%
2024/11/19196.0000.0096.0011,0150.10%
2024/11/1800.00198.4096.50-11,010-0.10%
2024/11/1400.001101.50101.50-1971-0.10%
2024/11/0500.001106.00106.00-1782-0.13%
2024/11/041100.001100.00100.0007580.00%
2024/11/0100.003108.00105.00-3730-0.41%
2024/09/24189.40189.4090.2006120.00%
2024/09/23188.1000.0088.0016200.16%
2024/09/20188.0000.0087.4016440.16%
2024/09/19286.4000.0086.0026360.31%
2024/09/04182.0000.0082.0016980.14%
2024/08/19184.3000.0084.5017390.14%
2024/08/16184.7000.0084.6017430.13%
2024/07/1800.00299.5099.40-2676-0.30%
2024/07/1500.00298.3098.40-2663-0.30%
2024/07/12195.7000.0095.6016480.15%
2024/07/11295.9500.0095.2026500.31%
2024/07/081100.50999.97100.50-8655-1.22%
2024/07/02199.2000.0097.8016230.16%
2024/07/0100.00299.90101.00-2610-0.33%
2024/06/2400.00293.2093.20-2589-0.34%
2024/06/1300.001696.9196.90-16651-2.46%
2024/05/3000.00391.6090.30-3737-0.41%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章